Profile
Gabriel R.
Cipau is an Executive Chairman of Phase Bioscience, Inc. He is a Director of ENS, Inc. and Bob Barker Co. and a Partner at Key Healthcare Partners.
Dr. Cipau was President and Chief Executive Officer of Nippon Wellcome Kk, Copley Pharmaceuticals, Catalytica Pharmaceuticals, and Biolex, Inc. He was Chief Executive Officer of Phase Bioscience until March, 2007.
Dr. Cipau holds an MBA and PhD.
Gabriel R. Cipau active positions
| Companies | Position | Start |
|---|---|---|
ENS, Inc.
ENS, Inc. Medical/Nursing ServicesHealth Services Home care nursing concern | Director/Board Member | - |
Former positions of Gabriel R. Cipau
| Companies | Position | End |
|---|---|---|
DSM Pharmaceuticals, Inc.
DSM Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical & biotechnology contract manufacturing services | President | - |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | President | - |
| PHASEBIO PHARMACEUTICALS, INC. | Chairman | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
DSM Pharmaceuticals, Inc.
DSM Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical & biotechnology contract manufacturing services | Health Technology |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Distribution Services |
PhaseBio Pharmaceuticals, Inc.
PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
ENS, Inc.
ENS, Inc. Medical/Nursing ServicesHealth Services Home care nursing concern | Health Services |
- Stock Market
- Insiders
- Gabriel R. Cipau
















